Pathological Mechanisms Linking Diabetes Mellitus and Alzheimer’s Disease: the Receptor for Advanced Glycation End Products (RAGE)

Pathological Mechanisms Linking Diabetes Mellitus and Alzheimer’s Disease: the Receptor for Advanced Glycation End Products (RAGE)

Diabetes and Alzheimer’s disease (AD) place a significant burden on health care systems in the world and its aging populations. These diseases have long been regarded as separate entities; however, advanced glycation end products (AGEs) and the receptors for AGEs (RAGE) may be a link between diabete...

Full description

Bibliographic Details
Main Authors:	Yanyan Kong, Fushuai Wang, Jiao Wang, Cuiping Liu, Yinping Zhou, Zhengqin Xu, Chencheng Zhang, Bomin Sun, Yihui Guan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-07-01
Series:	Frontiers in Aging Neuroscience
Subjects:	advanced glycation end products RAGE Alzheimer’s disease diabetes PI3K
Online Access:	https://www.frontiersin.org/article/10.3389/fnagi.2020.00217/full

Similar Items

Insulin resistance and generation of advanced glycation end products
by: Alvaro Gudiño Gomezjurado, et al.
Published: (2013-04-01)

In Patients with Chronic Kidney Disease Advanced Glycation End-Products Receptors Isoforms (sRAGE and esRAGE) Are Associated with Malnutrition
by: Lara Caldiroli, et al.
Published: (2022-06-01)

Effects of advanced glycation end products on stem cell
by: Zetai Zheng, et al.
Published: (2024-12-01)

Advanced glycation end products and their soluble receptor (sRAGE) in patients with Hashimoto’s thyroiditis on levothyroxine substitution
by: Sára Csiha, et al.
Published: (2023-05-01)

Receptor of advanced glycation end product (RAGE) polymorphism and oxidative status in Hashimoto’s thyroiditis in Egyptian female patients: case control study
by: Noura Mostafa Mohamed, et al.
Published: (2022-05-01)

The Assessment of Serum Concentrations of AGEs and Their Soluble Receptor (sRAGE) in Multiple Sclerosis Patients
by: Aleksandra Damasiewicz-Bodzek, et al.
Published: (2021-07-01)

Advanced glycation end products of dietary origin and their association with inflammation in diabetes – A minireview
by: Pedreanez Adriana, et al.
Published: (2024-01-01)

Allicin Alleviates Diabetes Mellitus by Inhibiting the Formation of Advanced Glycation End Products
by: Linzehao Li, et al.
Published: (2022-12-01)

Advanced Glycation End-Products (AGEs) and Their Soluble Receptor (sRAGE) in Women Suffering from Systemic Lupus Erythematosus (SLE)
by: Agnieszka Nowak, et al.
Published: (2021-12-01)

Assessment of Oral Glycine and Lysine Therapy on Receptor for Advanced Glycation End Products and Transforming Growth Factor Beta Expression in the Kidney of Streptozotocin-Induced Diabetic Rats in Comparison with Normal Rats
by: Somayeh Sadat Heidary, et al.
Published: (2014-01-01)

Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study
by: Eva O. Melin, et al.
Published: (2020-10-01)

RAGE is a critical factor of sex-based differences in age-induced kidney damage
by: Seerat Bajwa, et al.
Published: (2023-03-01)

AGEs and sRAGE Variations at Different Timepoints in Patients with Chronic Kidney Disease
by: Paolo Molinari, et al.
Published: (2021-12-01)

Galectin‐3 and RAGE differentially control advanced glycation endproduct‐induced collagen damage in murine intervertebral disc organ culture
by: Zachary S. Gallate, et al.
Published: (2023-06-01)

Do advanced glycation end products contribute to food allergy?
by: P. K. Smith, et al.
Published: (2023-04-01)

Methylglyoxal-Derived Nucleoside Adducts Drive Vascular Dysfunction in a RAGE-Dependent Manner
by: Seigmund Wai Tsuen Lai, et al.
Published: (2024-01-01)

S100B Impairs Oligodendrogenesis and Myelin Repair Following Demyelination Through RAGE Engagement
by: Gisela Santos, et al.
Published: (2020-09-01)

Association between Advanced Glycation End-Products and Sarcopenia in Patients with Chronic Kidney Disease
by: Paolo Molinari, et al.
Published: (2022-06-01)

Wnt Glycation Inhibits Canonical Signaling
by: Zhennan Ye, et al.
Published: (2019-10-01)

Fermented Fish Collagen Diminished Photoaging-Related Collagen Decrease by Attenuating AGE–RAGE Binding Activity
by: Seyeon Oh, et al.
Published: (2024-12-01)

HMGB1, S100 proteins and other RAGE ligands in cancer - markers, mediators and putative therapeutic targets
by: Petra Tesarova, et al.
Published: (2016-03-01)

Detection of receptor for advanced glycation end products (RAGE) and high mobility group protein box 1 HMGB1 levels in patients’ serum with breast cancer
by: Hind Shawqi Zaki, et al.
Published: (2023-01-01)

Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives
by: Mariyam Khalid, et al.
Published: (2022-04-01)

RAGE displays sex-specific differences in obesity-induced adipose tissue insulin resistance
by: Zuoqin Du, et al.
Published: (2022-11-01)

Pubertal exposure to dietary advanced glycation end products disrupts ductal morphogenesis and induces atypical hyperplasia in the mammary gland
by: Bradley A. Krisanits, et al.
Published: (2023-10-01)

esRAGE-expressing oHSV enhances anti-tumor efficacy by inhibition of endothelial cell activation
by: Jessica Swanner, et al.
Published: (2023-03-01)

Soluble receptors for advanced glycation end-products prevent unilateral ureteral obstruction-induced renal fibrosis
by: Chan Ho Kim, et al.
Published: (2023-05-01)

Could AGE/RAGE-Related Oxidative Homeostasis Dysregulation Enhance Susceptibility to Pathogenesis of Cardio-Metabolic Complications in Childhood Obesity?
by: Domenico Corica, et al.
Published: (2019-06-01)

Advanced Glycation End-Products (AGEs): Formation, Chemistry, Classification, Receptors, and Diseases Related to AGEs
by: Aleksandra Twarda-Clapa, et al.
Published: (2022-04-01)

N-Acetyl Cysteine Attenuated the Deleterious Effects of Advanced Glycation End-Products on the Kidney of Non-Diabetic Rats
by: Karina Thieme, et al.
Published: (2016-11-01)

RAGE contributes to allergen driven severe neutrophilic airway inflammation via NLRP3 inflammasome activation in mice
by: Katherine N. Killian, et al.
Published: (2023-01-01)

Association of Autofluorescent Advanced Glycation End Products (AGEs) with Frailty Components in Chronic Kidney Disease (CKD): Data from a Single-Center Cohort Study
by: Paolo Molinari, et al.
Published: (2023-01-01)

Anti-diabetic combination therapy with pioglitazone or glimepiride added to metformin on the AGE-RAGE axis: a randomized prospective study
by: Eugenio Ragazzi, et al.
Published: (2023-08-01)

Evaluation of circulating sRAGE in osteoporosis according to BMI, adipokines and fracture risk: a pilot observational study
by: Emanuela Galliera, et al.
Published: (2017-06-01)

Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications
by: Misganaw Asmamaw Mengstie, et al.
Published: (2022-09-01)

Redox Signaling and Advanced Glycation Endproducts (AGEs) in Diet-Related Diseases
by: Vanesa Cepas, et al.
Published: (2020-02-01)

Oleic Acid Status Positively Correlates with the Soluble Receptor for Advanced Glycation End-Products (sRAGE) in Healthy Adults Who Are Homozygous for G Allele of RAGE G82S Polymorphism
by: Permal Deo, et al.
Published: (2023-06-01)

Pathological Role of Receptor for Advanced Glycation End Products in Calcified Aortic Valve Stenosis
by: Kosuke Saku, et al.
Published: (2020-07-01)

Arginine Reduces Glycation in γ<sub>2</sub> Subunit of AMPK and Pathologies in Alzheimer’s Disease Model Mice
by: Rui Zhu, et al.
Published: (2022-11-01)

Alpha-Lipoic Acid Treatment Reduces the Levels of Advanced End Glycation Products in Type 2 Diabetes Patients with Neuropathy
by: Sára Csiha, et al.
Published: (2025-02-01)